SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-053057
Filing Date
2024-04-26
Accepted
2024-04-26 16:58:41
Documents
6
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2412804d1_def14a.htm DEF 14A 529271
2 GRAPHIC tm2412804d1_def14a001.jpg GRAPHIC 181767
3 GRAPHIC tm2412804d1_def14a002.jpg GRAPHIC 210310
4 GRAPHIC tm2412804d1_def14aimg001.jpg GRAPHIC 197030
5 GRAPHIC tm2412804d1_def14aimg002.jpg GRAPHIC 211485
6 GRAPHIC tm2412804d1_def14aimg01.jpg GRAPHIC 1529
  Complete submission text file 0001104659-24-053057.txt   1635869
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 24884875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)